Patents by Inventor Miaofen G. HU

Miaofen G. HU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PYRIDOPYRIMIDINE COMPOUNDS AND METHODS OF THEIR USE
    Publication number: 20210261547
    Abstract: Disclosed are compounds of formula (I) or a pharmaceutically acceptable salt thereof, where X is O or S; R1 is hydrogen, an optionally substituted C1-6 alkyl, or an optionally substituted C3-8 cycloalkyl; each of R2, R3, and R4 is independently hydrogen, halo, or an optionally substituted C1-6 alkyl; R5 is a substituted C3 heteroaryl; and R6 is hydrogen or an optionally substituted C1-6 alkyl. Also disclosed are pharmaceutical compositions and methods of their use.
    Type: Application
    Filed: June 27, 2019
    Publication date: August 26, 2021
    Inventor: Miaofen G. HU
  • Compositions and methods for treating and preventing metabolic disorders
    Patent number: 11077110
    Abstract: Provided herein are compositions and methods for treating or preventing metabolic disorders. In particular, provided herein are compositions, methods, and uses of Cyclin-dependent Kinase 6 (CDK6) inhibitors for treating and preventing metabolic diseases (e.g., type II diabetes, obesity, metabolic syndrome, elevated blood pressure, cardiovascular diseases, elevated fasting plasma glucose, and high serum triglycerides).
    Type: Grant
    Filed: March 17, 2017
    Date of Patent: August 3, 2021
    Assignee: Tufts Medical Center
    Inventor: Miaofen G. Hu
  • COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING METABOLIC DISORDERS
    Publication number: 20190192518
    Abstract: Provided herein are compositions and methods for treating or preventing metabolic disorders. In particular, provided herein are compositions, methods, and uses of Cyclin-dependent Kinase 6 (CDK6) inhibitors for treating and preventing metabolic diseases (e.g., type II diabetes, obesity, metabolic syndrome, elevated blood pressure, cardiovascular diseases, elevated fasting plasma glucose, and high serum triglycerides).
    Type: Application
    Filed: March 17, 2017
    Publication date: June 27, 2019
    Inventor: Miaofen G. HU